These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3794682)

  • 1. Views of Louisiana pharmacists on drug product selection.
    Iyriboz Y; Church G
    J La State Med Soc; 1986 Nov; 138(11):41-5. PubMed ID: 3794682
    [No Abstract]   [Full Text] [Related]  

  • 2. Physicians' attitudes toward generic drug substitution by pharmacists.
    Brust M; Hawkins CF; Grayson D
    Tex Med; 1990 Mar; 86(3):45-9. PubMed ID: 2333636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes of pharmacists and physicians toward Florida's drug product selection law.
    Vuturo GJ; McCormick WC; Krischer JP
    Contemp Pharm Pract; 1980; 3(3):156-62. PubMed ID: 10247871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ohio Generic Product Selection Law: influence on pharmacy practice.
    Hunter RH
    Med Mark Media; 1979 Jul; 14(7):33-6. PubMed ID: 10243269
    [No Abstract]   [Full Text] [Related]  

  • 5. American Society of Hospital Pharmacists. Product selection survey.
    Am J Hosp Pharm; 1972 Jun; 29(6):506. PubMed ID: 5035970
    [No Abstract]   [Full Text] [Related]  

  • 6. [Opinions of physicians and pharmacists on problems with drugs].
    Kolár J; Molenda F
    Ceska Slov Farm; 2003 Jul; 52(4):159-65. PubMed ID: 12924065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherent risk and market acceptance of generic drug products.
    Carroll NV; Wolfgang AP
    J Health Care Mark; 1989 Dec; 9(4):48-51. PubMed ID: 10296580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Views of Louisiana pharmacists on advertisement of prescription drugs.
    Iyriboz Y
    J La State Med Soc; 1987 Jun; 139(6):47-9. PubMed ID: 3612112
    [No Abstract]   [Full Text] [Related]  

  • 9. Perceptions of the elderly regarding pharmacies, drugs, and pharmacists.
    McCormick WC
    Pharm Manage Comb Am J Pharm; 1979; 151(2):90, 95. PubMed ID: 441154
    [No Abstract]   [Full Text] [Related]  

  • 10. Physician and pharmacist attitudes toward a generic incentive program.
    Colaizzi JL; Barone JA
    N J Med; 1986 Mar; 83(3):153-6. PubMed ID: 3458036
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug product equivalence--are specifications necessary?
    Bergen JV
    J Am Pharm Assoc; 1972 Jan; 12(1):21-5. PubMed ID: 5007259
    [No Abstract]   [Full Text] [Related]  

  • 12. [How do pharmacists evaluate the newly introduced system of substituting prescriptions?].
    Rubak SL; Andersen ML; Mainz J; Olesgaard P; Laursen K; Schaumann M; Lauritzen T
    Ugeskr Laeger; 2000 Nov; 162(45):6074-7. PubMed ID: 11107945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacists' perceptions and practices regarding the purchase of multisource pharmaceuticals.
    Sanborn MD; White SJ
    Hosp Pharm; 1993 Feb; 28(2):104-6, 109-13. PubMed ID: 10125701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Legal implications of generic drug substitution.
    Chewning JB
    Ohio State Med J; 1975 May; 71(5):323-6. PubMed ID: 1128867
    [No Abstract]   [Full Text] [Related]  

  • 15. Informed consent and generic drug substitution.
    DeVeaugh-Geiss J
    Clin Ther; 1985; 7(5):544-8. PubMed ID: 4053144
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacists' and physicians' attitudes toward pharmaceutical marketing practices.
    Poirier TI; Giannetti V; Giudici RA
    Am J Hosp Pharm; 1994 Feb; 51(3):378-81. PubMed ID: 8160692
    [No Abstract]   [Full Text] [Related]  

  • 17. How safe are generic drugs?
    Birdsall C; Uretsky S
    Am J Nurs; 1987 Apr; 87(4):431-2. PubMed ID: 3645956
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug product selection and the law.
    Fink JL
    Contemp Pharm Pract; 1979; 2(3):128-31. PubMed ID: 10242846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Product selection: community formularies and legal aspects. The pharmacist's responsibility in product selection.
    Kanig JL
    Am J Pharm Sci Support Public Health; 1972; 144(5):133-8. PubMed ID: 4641165
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioequivalence and interchangeability of narrow therapeutic range drugs. Canadian Society for Pharmaceutical Sciences discussion.
    Palylyk-Colwell E; Jamali F; Dryden W; Friesen E; Koven S; Mohamed I; Osmond B; Alessi-Severini S; Sheldon L; Sheldon R; Tam Y; Tsuyuki R; Zhanel G
    J Pharm Pharm Sci; 1998; 1(1):2-7. PubMed ID: 10942966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.